Tompkins, B. A., DiFede, D. L., Khan, A., Landin, A. M., Schulman, I. H., Pujol, M. V., . . . Hare, J. M. (2017). Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Gerontol A Biol Sci Med Sci.
Citação norma ChicagoTompkins, Bryon A., et al. "Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial." J Gerontol A Biol Sci Med Sci 2017.
MLA引文Tompkins, Bryon A., et al. "Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial." J Gerontol A Biol Sci Med Sci 2017.
警告：這些引文格式不一定是100％准確.